200 ng ml−1 il-4 Search Results


93
Kingfisher Biotech recombinant bovine il 4
Recombinant Bovine Il 4, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/Recombinant+Bovine+IL-4/pm27863548-48-24-35
Average 93 stars, based on 1 article reviews
recombinant bovine il 4 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
CreaGene Inc rh mouse il-4
Rh Mouse Il 4, supplied by CreaGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/rh+mouse+il+4/ppr0249729-118-20-26
Average 90 stars, based on 1 article reviews
rh mouse il-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

97
R&D Systems recombinant il 4
Recombinant Il 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/Recombinant+Mouse+IL-4+Protein/pmc05087743-730-9-11
Average 97 stars, based on 1 article reviews
recombinant il 4 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

90
ImmunoTools il-4 cytokine
Il 4 Cytokine, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/il+4+cytokine/pm34811790-40-36-37
Average 90 stars, based on 1 article reviews
il-4 cytokine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ImmunoTools il-4 immunotools
Il 4 Immunotools, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/recombinant+human+il+4/pm33368331-7-16-17
Average 90 stars, based on 1 article reviews
il-4 immunotools - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CreaGene Inc interleukin-4 (il-4)
Interleukin 4 (Il 4), supplied by CreaGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/il+4+cytokine/pm39330237-105-33-39
Average 90 stars, based on 1 article reviews
interleukin-4 (il-4) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ImmunoTools human il-4
Human Il 4, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/human+il+4/pmc07867296-217-68-72
Average 90 stars, based on 1 article reviews
human il-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ImmunoTools interleukin-4
Interleukin 4, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/interleukin+4/pmc05957431-100-33-34
Average 90 stars, based on 1 article reviews
interleukin-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

97
R&D Systems recombinant human interleukin 4
Recombinant Human Interleukin 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/Recombinant+Human+IL-4+Protein/pmc09899619-51-20-24
Average 97 stars, based on 1 article reviews
recombinant human interleukin 4 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

94
R&D Systems rp il 4
Rp Il 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/Recombinant+Porcine+IL-4+Protein/pm24648487-43-36-40
Average 94 stars, based on 1 article reviews
rp il 4 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Becton Dickinson il-4
IL-10 modulates muscle cell differentiation in vitro and in vivo. (A) Myoblasts were cultured without addition of exogenous factors (‘none') or in the presence of IL-10, LPS, LPS and IL-10 together or bFGF, and then assayed for cell number at the end of 3 days of stimulation. Neither IL-10, LPS or IL-10 combined with LPS affected proliferation, although bFGF, which was used as a positive control, increased cell number by nearly 50% under the same culture conditions. (B) Pre-treatment of macrophages with IFN-γ and TNF-α prior to co-culture with myoblasts decreased myoblast numbers at the end of a 3-day period of co-culture, compared with myoblasts cultured alone (‘none'). Pre-treatment of macrophages with IL-10 <t>or</t> <t>IL-4</t> combined with IL-13 to induce M2c phenotype generated macrophages that promoted myoblast proliferation in co-cultures. n = 6 for each treatment group. Asterisks indicate significant difference from the ‘none' group at P< 0.05. Bars represent sem. (C) Quantitative, real-time PCR results for relative mRNA levels for Pax7 in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Bars represent sem. (D) Western blots of extracts of myoblast cultures collected 0–7 days after initiating cultures in the presence of IL-10 or addition of no exogenous cytokine (‘none'). Blots were probed with antibodies to MyoD or myogenin. The membrane used for immunoblotting was stained with Ponceau red (‘Loading') before application of the antibody to verify equal protein loading in each lane. (E and F) Quantitative, real-time PCR results for relative mRNA levels for MyoD (E) or myogenin (F) in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Hash symbol indicates significant difference from age-matched IL-10+/+/mdx muscles. Asterisks indicate significant difference from 4-week-old IL-10+/+/mdx muscles. Bars represent sem.
Il 4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/il+4+cytokine/pmc03024048-574-34-37
Average 90 stars, based on 1 article reviews
il-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Becton Dickinson interleukin (il-4
IL-10 modulates muscle cell differentiation in vitro and in vivo. (A) Myoblasts were cultured without addition of exogenous factors (‘none') or in the presence of IL-10, LPS, LPS and IL-10 together or bFGF, and then assayed for cell number at the end of 3 days of stimulation. Neither IL-10, LPS or IL-10 combined with LPS affected proliferation, although bFGF, which was used as a positive control, increased cell number by nearly 50% under the same culture conditions. (B) Pre-treatment of macrophages with IFN-γ and TNF-α prior to co-culture with myoblasts decreased myoblast numbers at the end of a 3-day period of co-culture, compared with myoblasts cultured alone (‘none'). Pre-treatment of macrophages with IL-10 <t>or</t> <t>IL-4</t> combined with IL-13 to induce M2c phenotype generated macrophages that promoted myoblast proliferation in co-cultures. n = 6 for each treatment group. Asterisks indicate significant difference from the ‘none' group at P< 0.05. Bars represent sem. (C) Quantitative, real-time PCR results for relative mRNA levels for Pax7 in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Bars represent sem. (D) Western blots of extracts of myoblast cultures collected 0–7 days after initiating cultures in the presence of IL-10 or addition of no exogenous cytokine (‘none'). Blots were probed with antibodies to MyoD or myogenin. The membrane used for immunoblotting was stained with Ponceau red (‘Loading') before application of the antibody to verify equal protein loading in each lane. (E and F) Quantitative, real-time PCR results for relative mRNA levels for MyoD (E) or myogenin (F) in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Hash symbol indicates significant difference from age-matched IL-10+/+/mdx muscles. Asterisks indicate significant difference from 4-week-old IL-10+/+/mdx muscles. Bars represent sem.
Interleukin (Il 4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ml%E2%88%921+il-4/interleukin+4++il+4/pmc09499840-78-21-24
Average 90 stars, based on 1 article reviews
interleukin (il-4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


IL-10 modulates muscle cell differentiation in vitro and in vivo. (A) Myoblasts were cultured without addition of exogenous factors (‘none') or in the presence of IL-10, LPS, LPS and IL-10 together or bFGF, and then assayed for cell number at the end of 3 days of stimulation. Neither IL-10, LPS or IL-10 combined with LPS affected proliferation, although bFGF, which was used as a positive control, increased cell number by nearly 50% under the same culture conditions. (B) Pre-treatment of macrophages with IFN-γ and TNF-α prior to co-culture with myoblasts decreased myoblast numbers at the end of a 3-day period of co-culture, compared with myoblasts cultured alone (‘none'). Pre-treatment of macrophages with IL-10 or IL-4 combined with IL-13 to induce M2c phenotype generated macrophages that promoted myoblast proliferation in co-cultures. n = 6 for each treatment group. Asterisks indicate significant difference from the ‘none' group at P< 0.05. Bars represent sem. (C) Quantitative, real-time PCR results for relative mRNA levels for Pax7 in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Bars represent sem. (D) Western blots of extracts of myoblast cultures collected 0–7 days after initiating cultures in the presence of IL-10 or addition of no exogenous cytokine (‘none'). Blots were probed with antibodies to MyoD or myogenin. The membrane used for immunoblotting was stained with Ponceau red (‘Loading') before application of the antibody to verify equal protein loading in each lane. (E and F) Quantitative, real-time PCR results for relative mRNA levels for MyoD (E) or myogenin (F) in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Hash symbol indicates significant difference from age-matched IL-10+/+/mdx muscles. Asterisks indicate significant difference from 4-week-old IL-10+/+/mdx muscles. Bars represent sem.

Journal: Human Molecular Genetics

Article Title: Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype

doi: 10.1093/hmg/ddq523

Figure Lengend Snippet: IL-10 modulates muscle cell differentiation in vitro and in vivo. (A) Myoblasts were cultured without addition of exogenous factors (‘none') or in the presence of IL-10, LPS, LPS and IL-10 together or bFGF, and then assayed for cell number at the end of 3 days of stimulation. Neither IL-10, LPS or IL-10 combined with LPS affected proliferation, although bFGF, which was used as a positive control, increased cell number by nearly 50% under the same culture conditions. (B) Pre-treatment of macrophages with IFN-γ and TNF-α prior to co-culture with myoblasts decreased myoblast numbers at the end of a 3-day period of co-culture, compared with myoblasts cultured alone (‘none'). Pre-treatment of macrophages with IL-10 or IL-4 combined with IL-13 to induce M2c phenotype generated macrophages that promoted myoblast proliferation in co-cultures. n = 6 for each treatment group. Asterisks indicate significant difference from the ‘none' group at P< 0.05. Bars represent sem. (C) Quantitative, real-time PCR results for relative mRNA levels for Pax7 in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Bars represent sem. (D) Western blots of extracts of myoblast cultures collected 0–7 days after initiating cultures in the presence of IL-10 or addition of no exogenous cytokine (‘none'). Blots were probed with antibodies to MyoD or myogenin. The membrane used for immunoblotting was stained with Ponceau red (‘Loading') before application of the antibody to verify equal protein loading in each lane. (E and F) Quantitative, real-time PCR results for relative mRNA levels for MyoD (E) or myogenin (F) in quadriceps muscles of 4-week-old or 12-week-old mdx mice that expressed IL-10 (+/+) or were IL-10 null mutants (−/−). Expression levels are relative to 4-week-old IL-10+/+/mdx muscles, for which the expression level is set at one unit. Each experimental group included quadriceps from five mice. Hash symbol indicates significant difference from age-matched IL-10+/+/mdx muscles. Asterisks indicate significant difference from 4-week-old IL-10+/+/mdx muscles. Bars represent sem.

Article Snippet: Peritoneal macrophages were seeded at 4.0×10 5 cells/well in six-well plates and stimulated with mouse recombinant IFN-γ (10 ng/ml, BD Pharmingen) and TNF-α (10 ng/ml, BD Pharmingen) or IL-10 (10 ng/ml, BD Pharmingen) or IL-4 (10 ng/ml, BD Pharmingen) and IL-13 (10 ng/ml, BD Pharmingen) in DMEM containing 0.25% FBS and 1% penicillin–streptomycin (P/S) for 24 h at 37°C and 5% CO 2 .

Techniques: Cell Differentiation, In Vitro, In Vivo, Cell Culture, Positive Control, Co-Culture Assay, Generated, Real-time Polymerase Chain Reaction, Expressing, Western Blot, Staining

IL-10 induces phagocytosis by macrophages and clodronate depletion of phagocytes from mdx mice selectively reduces M2c macrophages in skeletal muscle. (A–D) Flow cytometric data showing that IL-10 stimulation of macrophages increases macrophage phagocytosis. Macrophages were untreated with exogenous cytokines (A), treated with IFN-γ (B), IL-4 (C) or IL-10 (D) prior to incubation with flourescent microspheres for phagocytosis. Cells were then analyzed by flow cytometry to determine the proportion of cells that contained fluorescent microspheres, as an index of phagocytosis. Neither IFN-γ (68.1%) or IL-4 (61.2%) increased the proportion of cells that were phagocytic, compared with untreated controls (69.4%). However, IL-10 treatments increased the proportion of cells that were phagocytic (79.5%). (E and F) Intraperitoneal injections of clodronate-containing liposomes significantly reduced the numbers of macrophages (E) and MHC-2-presenting cells in the quadriceps muscles of 4-week-old mdx mice. Each experimental group included muscles from six mice. Asterisks indicate a significant difference from PBS-treated controls. Bars represent sem. (G–J) Quantitative, real-time PCR data show that clodronate-mediated depletions of phagocytes did not cause a significant change in the expression of CD68 in the quadriceps muscles of 4-week-old mdx mice (G), but caused large, significant reductions in the expression of CD206 (H), CD163 (I) and IL-10 (J). Each experimental group included muscles from five mice. Asterisks indicate a significant difference from PBS-treated controls. ‘n.s.' indicates no significant effect of the clodronate treatment. Bars represent sem, which is too small to appear for graphs of some data sets.

Journal: Human Molecular Genetics

Article Title: Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype

doi: 10.1093/hmg/ddq523

Figure Lengend Snippet: IL-10 induces phagocytosis by macrophages and clodronate depletion of phagocytes from mdx mice selectively reduces M2c macrophages in skeletal muscle. (A–D) Flow cytometric data showing that IL-10 stimulation of macrophages increases macrophage phagocytosis. Macrophages were untreated with exogenous cytokines (A), treated with IFN-γ (B), IL-4 (C) or IL-10 (D) prior to incubation with flourescent microspheres for phagocytosis. Cells were then analyzed by flow cytometry to determine the proportion of cells that contained fluorescent microspheres, as an index of phagocytosis. Neither IFN-γ (68.1%) or IL-4 (61.2%) increased the proportion of cells that were phagocytic, compared with untreated controls (69.4%). However, IL-10 treatments increased the proportion of cells that were phagocytic (79.5%). (E and F) Intraperitoneal injections of clodronate-containing liposomes significantly reduced the numbers of macrophages (E) and MHC-2-presenting cells in the quadriceps muscles of 4-week-old mdx mice. Each experimental group included muscles from six mice. Asterisks indicate a significant difference from PBS-treated controls. Bars represent sem. (G–J) Quantitative, real-time PCR data show that clodronate-mediated depletions of phagocytes did not cause a significant change in the expression of CD68 in the quadriceps muscles of 4-week-old mdx mice (G), but caused large, significant reductions in the expression of CD206 (H), CD163 (I) and IL-10 (J). Each experimental group included muscles from five mice. Asterisks indicate a significant difference from PBS-treated controls. ‘n.s.' indicates no significant effect of the clodronate treatment. Bars represent sem, which is too small to appear for graphs of some data sets.

Article Snippet: Peritoneal macrophages were seeded at 4.0×10 5 cells/well in six-well plates and stimulated with mouse recombinant IFN-γ (10 ng/ml, BD Pharmingen) and TNF-α (10 ng/ml, BD Pharmingen) or IL-10 (10 ng/ml, BD Pharmingen) or IL-4 (10 ng/ml, BD Pharmingen) and IL-13 (10 ng/ml, BD Pharmingen) in DMEM containing 0.25% FBS and 1% penicillin–streptomycin (P/S) for 24 h at 37°C and 5% CO 2 .

Techniques: Incubation, Flow Cytometry, Real-time Polymerase Chain Reaction, Expressing